1
|
Fang JS, Deng YW, Li MC, Chen FH, Wang YJ,
Lu M, Fang F, Wu J, Yang ZY, Zhou XY, et al: Isolation and
identification of brain tumor stem cells from human brain
neuroepithelial tumors. Zhonghua Yi Xue Za Zhi. 87:298–303. 2007.In
Chinese. PubMed/NCBI
|
2
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al European organisation for Research and Treatment of Cancer
Brain Tumor and Radiotherapy Groups; National Cancer Institute of
Canada Clinical Trials Group: Radiotherapy plus concomitant and
adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996.
2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Komotar RJ, Otten ML, Moise G and Connolly
ES Jr: Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma-a critical review. Clin Med Oncol. 2:421–422.
2008.PubMed/NCBI
|
4
|
Enting RH, van der Graaf WT, Kros JM,
Heesters M, Metzemaekers J and den Dunnen W: Radiotherapy plus
concomitant and adjuvant temozolomide for leptomeningeal pilomyxoid
astrocytoma: A case study. J Neurooncol. 80:107–108. 2006.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Frosina G: Stem cell-mediated delivery of
therapies in the treatment of glioma. Mini Rev Med Chem.
11:591–598. 2011. View Article : Google Scholar : PubMed/NCBI
|
6
|
Dietrich J, Diamond EL and Kesari S:
Glioma stem cell signaling: Therapeutic opportunities and
challenges. Expert Rev Anticancer Ther. 10:709–722. 2010.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
8
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
9
|
Galli R, Binda E, Orfanelli U, Cipelletti
B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi
A: Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Plummer RS, Shea CR, Nelson M, Powell SK,
Freeman DM, Dan CP and Lang D: PAX3 expression in primary melanomas
and nevi. Mod Pathol. 21:525–530. 2008. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ryu B, Kim DS, Deluca AM and Alani RM:
Comprehensive expression profiling of tumor cell lines identifies
molecular signatures of melanoma progression. PLOS One. 2:e5942007.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Liu F, Cao J, Lv J, Dong L, Pier E, Xu GX,
Wang RA, Xu Z, Goding C and Cui R: TBX2 expression is regulated by
PAX3 in the melanocyte lineage. Pigment Cell Melanoma Res.
26:67–77. 2013. View Article : Google Scholar
|
13
|
Liu Y, Zhu H, Liu M, Du J, Qian Y, Wang Y,
Ding F and Gu X: Downregulation of Pax3 expression correlates with
acquired GFAP expression during NSC differentiation towards
astrocytes. FEBS Lett. 585:1014–1020. 2011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Gomes FC, Paulin D and Moura Neto V: Glial
fibrillary acidic protein (GFAP): Modulation by growth factors and
its implication in astrocyte differentiation. Braz J Med Biol Res.
32:619–631. 1999. View Article : Google Scholar : PubMed/NCBI
|
15
|
Chen J, Xia L, Wu X, Xu L, Nie D, Shi J,
Xu X, Ni L, Ju S, Wu X, et al: Clinical significance and prognostic
value of PAX3 expression in human glioma. J Mol Neurosci. 47:52–58.
2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Xia L, Huang Q, Nie D, Shi J, Gong M, Wu
B, Gong P, Zhao L, Zuo H, Ju S, et al: PAX3 is overexpressed in
human glioblastomas and critically regulates the tumorigenicity of
glioma cells. Brain Res. 1521:68–78. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Cebolla B and Vallejo M: Nuclear factor-I
regulates glial fibrillary acidic protein gene expression in
astrocytes differentiated from cortical precursor cells. J
Neurochem. 97:1057–1070. 2006. View Article : Google Scholar : PubMed/NCBI
|
18
|
Cao L, Yu Y, Bilke S, Walker RL,
Mayeenuddin LH, Azorsa DO, Yang F, Pineda M, Helman LJ and Meltzer
PS: Genome-wide identification of PAX3-FKHR binding sites in
rhabdomyosarcoma reveals candidate target genes important for
development and cancer. Cancer Res. 70:6497–6508. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Blair A, Hogge DE, Ailles LE, Lansdorp PM
and Sutherland HJ: Lack of expression of Thy-1 (CD90) on acute
myeloid leukemia cells with long-term proliferative ability in
vitro and in vivo. Blood. 89:3104–3112. 1997.PubMed/NCBI
|
20
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
21
|
Wang J, Guo LP, Chen LZ, Zeng YX and Lu
SH: Identification of cancer stem cell-like side population cells
in human nasopharyngeal carcinoma cell line. Cancer Res.
67:3716–3724. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ignatova TN, Kukekov VG, Laywell ED,
Suslov ON, Vrionis FD and Steindler DA: Human cortical glial tumors
contain neural stem-like cells expressing astroglial and neuronal
markers in vitro. Glia. 39:193–206. 2002. View Article : Google Scholar : PubMed/NCBI
|
23
|
Rafii S: Circulating endothelial
precursors: Mystery, reality, and promise. J Clin Invest.
105:17–19. 2000. View
Article : Google Scholar : PubMed/NCBI
|
24
|
Uchida N, Buck DW, He D, Reitsma MJ, Masek
M, Phan TV, Tsukamoto AS, Gage FH and Weissman IL: Direct isolation
of human central nervous system stem cells. Proc Natl Acad Sci USA.
97:14720–14725. 2000. View Article : Google Scholar : PubMed/NCBI
|